全文获取类型
收费全文 | 5022篇 |
免费 | 380篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 94篇 |
儿科学 | 140篇 |
妇产科学 | 135篇 |
基础医学 | 604篇 |
口腔科学 | 185篇 |
临床医学 | 538篇 |
内科学 | 873篇 |
皮肤病学 | 73篇 |
神经病学 | 235篇 |
特种医学 | 572篇 |
外科学 | 696篇 |
综合类 | 88篇 |
一般理论 | 6篇 |
预防医学 | 418篇 |
眼科学 | 49篇 |
药学 | 373篇 |
1篇 | |
肿瘤学 | 338篇 |
出版年
2022年 | 32篇 |
2021年 | 83篇 |
2020年 | 51篇 |
2019年 | 79篇 |
2018年 | 71篇 |
2017年 | 71篇 |
2016年 | 83篇 |
2015年 | 97篇 |
2014年 | 130篇 |
2013年 | 164篇 |
2012年 | 234篇 |
2011年 | 264篇 |
2010年 | 144篇 |
2009年 | 129篇 |
2008年 | 201篇 |
2007年 | 226篇 |
2006年 | 195篇 |
2005年 | 198篇 |
2004年 | 165篇 |
2003年 | 189篇 |
2002年 | 141篇 |
2001年 | 120篇 |
2000年 | 112篇 |
1999年 | 106篇 |
1998年 | 127篇 |
1997年 | 118篇 |
1996年 | 102篇 |
1995年 | 89篇 |
1994年 | 59篇 |
1993年 | 83篇 |
1992年 | 58篇 |
1991年 | 69篇 |
1990年 | 78篇 |
1989年 | 101篇 |
1988年 | 90篇 |
1987年 | 89篇 |
1986年 | 105篇 |
1985年 | 121篇 |
1984年 | 83篇 |
1983年 | 76篇 |
1982年 | 49篇 |
1981年 | 59篇 |
1980年 | 55篇 |
1978年 | 45篇 |
1977年 | 48篇 |
1976年 | 53篇 |
1975年 | 46篇 |
1972年 | 29篇 |
1971年 | 30篇 |
1966年 | 30篇 |
排序方式: 共有5418条查询结果,搜索用时 343 毫秒
991.
Neuroblastomas (NBs) with favorable outcome usually express TrkA, whereas unfavorable NBs frequently express TrkB and its cognate ligand BDNF. P75 (p75(LNTR), NGFR, TNFRSF16) binds NGF-related neurotrophins with low affinity and usually is coexpressed with Trk receptors in NBs. Here, we investigated the importance of p75 coexpression with Trk receptors in NBs. We transfected p75 into two Trk-null NB cell lines, SH-SY5Y and NLF that were also engineered to stably express TrkA or TrkB. Cell numbers were compared between single (Trk alone) and double (Trk+p75) transfectants, and proliferation was assessed by flow cytometry. P75 coexpression had little effect on cell growth in Trk NB cells in the absence of ligand, but it increased sensitivity and greatly enhanced the effect of cognate ligand. Exogenous NGF induced greater phosphorylation of TrkA and AKT. This was associated with increased cell number in TrkA/p75 cells compared to TrkA cells (p<0.01), which was due to increased proliferation in TrkA/p75 cells (p<0.05), followed by differentiation. Exogenous BDNF also increased cell number in TrkB/p75 compared to TrkB cells (p<0.01), due to an increase in proliferation, but without differentiation. Coexpression of p75 also increased specificity of Trk-expressing cells to ligand. NT3-induced phosphorylation of TrkA and AKT was reduced in TrkA/p75 cells. NT3-induced phosphorylation of TrkB (as well as AKT and MAPK) was also reduced with p75 coexpression. Our results suggest that p75 plays an important role in enhancing both the sensitivity of Trk receptors to low levels of ligand, as well as increasing the specificity of Trks to their cognate ligands. It also enhances ligand-induced differentiation in TrkA/p75 but not TrkB/p75 cells. 相似文献
992.
Karlsson LO Bergh N Li L Bissessar E Bobrova I Gross GJ Akyürek LM Grip L 《European journal of pharmacology》2012,674(2-3):378-383
Opioids confer cardioprotection after myocardial ischaemia and reperfusion. The primary aim of the present study was to evaluate the cardioprotective effect of different doses of enkephalin analogue Eribis peptide 94 (EP 94) in a porcine model of ischaemia and reperfusion. A secondary aim was to analyse the impact of ischaemia and reperfusion on the expression of opioid receptor subtypes in the porcine heart. Thirty-four anesthetised pigs underwent 40 min of balloon occlusion of the left anterior descending coronary artery followed by four hours of reperfusion. Pigs were given either vehicle (0.9% NaCl) or one of four doses of EP 94 (0.2, 1, 5 or 25 ug/kg at each administration, respectively), intravenously after 26, 33 and 40 min of ischaemia. Hearts were stained to quantify area at risk and infarct size. mRNA and protein expressions of the opioid receptor subtypes were detected with RT-PCR, immunoblotting and immunohistochemistry in the control and ischaemic/reperfused areas. There was a significant dose-response relationship between higher doses of EP 94 and reduced infarct size. Expression of κ- and δ-opioid receptors was detected at both mRNA and protein levels. In ischaemic/reperfused areas, an increased expression of mRNA for both receptors was observed, whereas only protein expression for the δ subtype was up-regulated. The μ-opioid receptor was not detected. 相似文献
993.
Yazdi K. Pithavala Warren Tong Janessa Mount Sadayappan V. Rahavendran May Garrett Brian Hee Paulina Selaru Nenad Sarapa Karen J. Klamerus 《Investigational new drugs》2012,30(1):273-281
Objective Axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptors 1, 2, and
3, is metabolized primarily by cytochrome P450 (CYP) 3A with minor contributions from CYP1A2, CYP2C19, and glucuronidation.
Co-administration with CYP inhibitors may increase systemic exposure to axitinib and alter its safety profile. This study
evaluated changes in axitinib plasma pharmacokinetic parameters and assessed safety and tolerability in healthy subjects,
following axitinib co-administration with the potent CYP3A inhibitor ketoconazole. Methods In this randomized, single-blind, two-way crossover study, 32 healthy volunteers received placebo, followed by a single 5-mg
oral dose of axitinib, administered either alone or on the fourth day of dosing with oral ketoconazole (400 mg/day for 7 days).
Results Axitinib exposure was significantly increased in the presence of ketoconazole, with a geometric mean ratio for area under
the plasma concentration–time curve from time zero to infinity of 2.06 (90% confidence interval [CI]: 1.84–2.30) and a geometric
mean ratio for maximum plasma concentration (Cmax) of 1.50 (90% CI: 1.33–1.70). For axitinib alone or with ketoconazole, Cmax occurred 1.5 and 2.0 h after dosing, respectively. Adverse events were predominantly mild; the most commonly reported treatment-related
adverse events were headache and nausea. Conclusions Axitinib plasma exposures and peak concentrations were increased following concurrent administration of axitinib and ketoconazole
in healthy volunteers. Axitinib alone and in combination with ketoconazole was well tolerated. These findings provide an upper
exposure for expected axitinib plasma concentrations in the presence of potent metabolic inhibition. 相似文献
994.
Swamy GK Garrett ME Miranda ML Ashley-Koch AE 《American journal of medical genetics. Part A》2011,155(6):1264-1271
Racial disparity in pregnancy outcomes is one of the most striking and poorly understood inequalities in American health. Genetic variability may be an important host factor influencing disparate birth outcomes between non-Hispanic black (NHB) and non-Hispanic white (NHW) women. Race-specific allelic frequencies in the vitamin D receptor (VDR) gene suggest its potential as a gene involved in health disparities. The Healthy Pregnancy, Healthy Baby Study is a prospective cohort of pregnant women aimed at identifying genetic, social, and environmental contributors to disparities in pregnancy outcomes in Durham, NC. VDR haplotype tagging single nucleotide polymorphisms (SNPs) were genotyped via Taqman assays for 615 women. Analysis of variance was used to examine the association between maternal genotype and infant birthweight. Eight of 38 SNPs examined showed nominal significance among NHB women, with one VDR SNP (rs7975232) surpassing the multiple testing significance threshold. rs7975232, an anonymous polymorphism, is part of a VDR gene haplotype associated with variation in mRNA stability. mRNA stability can affect the amount of protein produced, thus directly affecting vitamin D levels and calcium homeostasis. In contrast to NHBs, there was no association between any VDR SNP and birthweight for NHWs. Genetic factors contributing to disparities in birth outcomes are not expected to be explained entirely by variation in a single gene. Nevertheless, our results suggest that maternal VDR gene polymorphisms do influence birthweight with differential effects accruing across racial groups. Further research identifying the functionality of VDR gene polymorphisms in pregnant women will improve our understanding of the underlying mechanisms influencing birthweight. 相似文献
995.
Smith GC Chamberlain L Faxius L Johnston GW Jin S Bjursten LM 《Acta biomaterialia》2011,7(8):3209-3215
Titanium is widely used clinically, yet little is known regarding the effects of modifying its three-dimensional surface geometry at the nanoscale level. In this project we have explored the in vivo response in terms of nitric oxide scavenging and fibrotic capsule formation to nano-modified titanium implant surfaces. We compared titanium dioxide (TiO(2)) nanotubes with 100 nm diameters fabricated by electrochemical anodization with TiO(2) control surfaces. Significantly lower nitric oxide was observed for the nanostructured surface in solution, suggesting that nanotubes break down nitric oxide. To evaluate the soft tissue response in vivo TiO(2) nanotube and TiO(2) control implants were placed in the rat abdominal wall for 1 and 6 weeks. A reduced fibrotic capsule thickness was observed for the nanotube surfaces for both time points. Significantly lower nitric oxide activity, measured as the presence of nitrotyrosine (P<0.05), was observed on the nanotube surface after 1 week, indicating that the reactive nitrogen species interaction is of importance. The differences observed between the titanium surfaces may be due to the catalytic properties of TiO(2), which are increased by the nanotube structure. These findings may be significant for the interaction between titanium implants in soft tissue as well as bone tissue and provide a mechanism by which to improve future clinical implants. 相似文献
996.
997.
998.
Cortical compression can be a significant problem in many types of brain injuries, such as brain trauma, localized brain edema, hematoma, focal cerebral ischemia, or brain tumors. Mechanical and cellular alterations can result in global changes in excitation and inhibition on the neuronal network level even in the absence of histologically significant cell injury, often manifesting clinically as seizures. Despite the importance and prevalence of this problem, however, the precise electrophysiological effects of brain injury have not been well characterized. In this study, the changes in electrophysiology were characterized following sustained cortical compression using large-scale, multielectrode measurement of multiunit activity in primary somatosensory cortex in a sensory-evoked, in vivo animal model. Immediately following the initiation of injury at a distal site, there was a period of suppression of the evoked response in the rat somatosensory cortex, followed by hyper-excitability that was accompanied by an increase in the spatial extent of cortical activation. Paired-pulse tactile stimulation revealed a dramatic shift in the excitatory/inhibitory dynamics, suggesting a longer term hyperexcitability of the cortical circuit following the initial suppression that could be linked to the disruption of one or more inhibitory mechanisms of the thalamocortical circuit. Together, our results showed that the use of a sensory-evoked response provided a robust and repeatable functional marker of the evolution of the consequences of mild injury, serving as an important step toward in vivo quantification of alterations in excitation and inhibition in the cortex in the setting of traumatic brain injury. 相似文献
999.
1000.